Event Details
Phase 1: Where Science Becomes Medicine
Sunday, July 14, 2019 - Tuesday, July 16, 2019
Title
Phase 1: Where Science Becomes Medicine
Date / Time
Sunday, July 14, 2019 - Tuesday, July 16, 2019
Location
Hilton Deansgate, Manchester, United Kingdom
Notes
Poster presentations:
- A Phase 1b Study of Oraxol in Combination with Ramucirumab in Patients with Gastric or Esophageal Cancers who failed previous chemotherapy
- Oral paclitaxel for the treatment of metastatic breast cancer (MBC) patients
- Phase 1 Trial Summary of Encequidar, a Novel P-glycoprotein (P-gp) Inhibitor to Enhance Oral Bioavailability of Chemotherapies
- A pilot study of oral paclitaxel and encequidar in patients with cutaneous angiosarcomas (KX-ORAX-010)